GLYCOSYLATED HAEMOGLOBIN DECREASED

This adverse event was reported 1246 times

These drugs are most commonly taken by patients reporting GLYCOSYLATED HAEMOGLOBIN DECREASED:

# Drug Count
0 METFORMIN 212
1 METFORMIN ER 500 MG 196
2 METFORMIN ER 750 MG 196
3 INSULIN GLARGINE 161
4 EMPAGLIFLOZIN 107
5 DULAGLUTIDE 103
6 SACUBITRIL AND VALSARTAN 89
7 INSULIN LISPRO 80
8 EXENATIDE 73
9 LIRAGLUTIDE 68
See all common drugs associated with GLYCOSYLATED HAEMOGLOBIN DECREASED

GLYCOSYLATED HAEMOGLOBIN DECREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 EMPAGLIFLOZIN AND LINAGLIPTIN 12 0.0071
1 VITAMIN A PALMITATE 1 0.0048
2 MIFEPRISTONE 18 0.0047
3 ALOGLIPTIN AND PIOGLITAZONE 1 0.0041
4 PANTHENOL 1 0.0038
5 ERTUGLIFLOZIN 3 0.0038
6 ESTRADIOL AND NORETHINDRONE ACETATE 1 0.0032
7 EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE 6 0.0030
8 EMPAGLIFLOZIN 107 0.0025
9 BETAXOLOL HYDROCHLORIDE 1 0.0025
See all drugs enriched for association with GLYCOSYLATED HAEMOGLOBIN DECREASED

GLYCOSYLATED HAEMOGLOBIN DECREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Progestin Antagonist [EPC] 18 0.0047
1 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 124 0.0027
2 Dipeptidyl Peptidase 4 Inhibitor [EPC] 40 0.0016
3 Isocitrate Dehydrogenase 1 Inhibitor [EPC] 2 0.0015
4 GLP-1 Receptor Agonist [EPC] 314 0.0013
5 Leptin Analog [EPC] 1 0.0010
6 Insulin [EPC] 46 0.0010
7 Sulfonylurea [EPC] 89 0.0008
8 Insulin Analog [EPC] 244 0.0007
9 alpha-Hydroxy Acid [EPC] 1 0.0007
See all drug classes enriched for association with GLYCOSYLATED HAEMOGLOBIN DECREASED